WO1997020829A1 - Process for preparing 2-chlorothiazole compounds - Google Patents
Process for preparing 2-chlorothiazole compounds Download PDFInfo
- Publication number
- WO1997020829A1 WO1997020829A1 PCT/IB1996/001329 IB9601329W WO9720829A1 WO 1997020829 A1 WO1997020829 A1 WO 1997020829A1 IB 9601329 W IB9601329 W IB 9601329W WO 9720829 A1 WO9720829 A1 WO 9720829A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- compound
- unsubstituted
- preparation
- reacting
- Prior art date
Links
- 0 *SC(*=NC1)SC1=C Chemical compound *SC(*=NC1)SC1=C 0.000 description 2
- YQRRLOOOZNMRIP-UHFFFAOYSA-N C=C(CN1)SC1=S Chemical compound C=C(CN1)SC1=S YQRRLOOOZNMRIP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Definitions
- the invention relates to a process for preparing a compound of the formula
- X is CH or N
- Y is NO 2 or CN
- Z is CHR 3 , O, NR 3 or S,
- R 1 and R 2 are either each, independently of the other, hydrogen or unsubstituted or R 4 , substituted alkyl or together a two- or three-membered alkylene bridge or a two- or three-membered alkylene bridge in which one member is replaced by a hetero member selected from the group, consisting of NR 5 , O and S,
- R 4 is an unsubstituted or substituted aryl or heteroaryl group
- R 5 is H or alkyl
- n 0, 1 or 2
- R 7 is unsubstituted or R 4 -substituted alkyl, unsubstituted or R 4 -substituted alkenyl, unsubstituted or R 4 -substituted alkynyl, cycloalkyl, unsubstituted or substituted aryl, heteroaryl or a group of the formula
- R 8 is an unsubstituted or substituted aryl or heteroaryl group, -COOH, COOM, wherein M is an alkali metal, or -COO-C 1 -C 8 -alkyl,
- R 6 and n are as defined for the formula II and X 1 is a leaving group, in the presence or absence of a base, with a compound of the formula
- Carbon-containing groups and compounds each contain, unless defined otherwise, 1 up to and including 8, preferably 1 up to and including 6, in particular 1 up to and including 4, especially 1 or 2 carbon atoms.
- Alkyl - as a group per se and also as a structural element of other groups and compounds, for example alkoxy and alkylthio - is, in each case with due regard to the number of carbon atoms contained in the respective group or compound, either straight-chain, i.e. methyl, ethyl, propyl, butyl, pentyl or hexyl, or branched, for example isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, neopentyl or isohexyl.
- Alkenyl and alkynyl are straight-chain or branched and each contain two or preferably one unsaturated carbon-carbon bond(s). The double or triple bonds of these substituents are separated from the remainder of the compound II preferably by at least one saturated carbon atom. Examples include allyl, methallyl, but-2-enyl, but-3-enyl, propargyl, but-2-ynyl and but-3-ynyl.
- Cycloalkyl is cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl, preferably cyclopropyl.
- Alkylene - as a group per se and also as a structural element of other groups and compounds, such as (alkylene)SR 7 - is, in each case with due regard to the number of carbon atoms contained in the respective group or compound, either straight-chain, for example -CH 2 CH 2 -, -CH 2 CH 2 CH 2 - or -CH 2 CH 2 CH 2 CH 2 -, or branched, for example -CH(CH 3 )--CH(C 2 H 5 )-, -C(CH 3 ) 2 -, - CH(CH 3 )CH 2 - or -CH(CH 3 )CH(CH 3 )-, and it can also be methylene.
- Aryl is phenyl or naphthyl, in particular phenyl.
- Heteroaryl is a 5- to 7-membered aromatic ring with one to up to three hetero atoms selected from the group consisting of N, O and S. Preference is given to aromatic 5- and 6-membered rings which have a nitrogen atom as hetero atom and which can, if desired, also contain a further hetero atom, preferably nitrogen or sulfur, in particular nitrogen.
- Substituted aryl and heteroaryl are preferably substitueted with one to three substituents selected from the group consisting of halogen, NO 2 , CN, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, halogen- C 1 -C 4 alkyl and halogenC 1 -C 4 alkoxy.
- Preferred are unsubstituted or monosubstituted, especially unsubstituted aryl and heteroaryl.
- Preferred starting materials for preparing the corresponding compounds of the formula I according to the invention are:
- X is N
- Y is NO 2 ;
- Z is CHR 3 or NR 3 , preferably NR 3 ;
- R 1 and R 2 are together a two- or three-membered alkylene bridge with or without a hetero member selected from the group consisting of NR 5 , O and S;
- R 3 is unsubstituted or R 4 -substituted C 1 -C 4 alkyl
- R 4 is unsubstituted or substituted aryl or heteroaryl, the substituents being selected from the group consisting of halogen, NO 2 , CN, C 1 -C 4 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 4 alkoxy and C 1 -C 4 alkylthio,
- R 6 is unsubstituted or R 8 -substituted C 1 -C 4 alkyl, aryl, heteroaryl, SR 7 , (alkylen)SH or (alkylene)SR 7 ,
- R 8 -substituted C 1 -C 2 alkyl or especially aryl
- R 7 is unsubstituted or R 4 -substituted alkyl, aryl, heteroaryl or a group of the formula
- R 8 is aryl or heteroaryl, which are either unstubstituted or substituted, the substituents being selected from the group consisting of halogen, NO 2 , CN, C 1 -C 4 -alkyl, C 3 -C 6 - cycloalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -alkylthio;
- reaction described hereinbefore and hereinafter are carried out in a customary manner, for example in the absence or usually in the presence of a suitable solvent or diluent or a mixture thereof, working as the occasion demands with cooling, at room temperature or with heating, for example at a temperature in the range of from about -80°C to the boiling point of the reaction medium, preferably at about -20°C to about +150°C, and, if necessary, in a closed vessel, at elevated pressure, in an inert-gas atmosphere and/or under anhydrous conditions.
- a suitable solvent or diluent or a mixture thereof working as the occasion demands with cooling, at room temperature or with heating, for example at a temperature in the range of from about -80°C to the boiling point of the reaction medium, preferably at about -20°C to about +150°C, and, if necessary, in a closed vessel, at elevated pressure, in an inert-gas atmosphere and/or under anhydrous conditions.
- Suitable halogenating agents are for example elemental chlorine, Javelle water, polysulfur dichloride, sulfur dichloride, phosphorus trichloride, phosphorus pentachloride or mixtures of two or more than two of these compounds, preferably elemental chlorine, Javelle water, sulfur dichloride or a mixture of these two compounds, particularly preferably elemental chlorine of Javelle water.
- the reaction partners can be reacted with each other without the addition of a solvent or diluent. It may, however, be advantageous to add a solvent or a diluent or a mixture thereof, in which case the amount thereof is not critical.
- solvents or diluents are: water; alcohols, such as methanol, ethanol, propanol, isopropanol, butanol, ethylene glycol or glycerol; aromatic, aliphatic and alicyclic hydrocarbons and halogenated hydrocarbons, such as benzene, toluene, xylene, mesitylene, tetraline, chlorobenzene, dichlorobenzene, bromobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, trichloromethane, carbon tetrachloride, dichloroethane, trichloroethene or tetrachloroethene; ethers, such as diethyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, ethylene glycol monomethyl ether,
- the reaction is preferably carried out in the presence of a halogenated hydrocarbon, in particular dichloromethane or chlorobenzene.
- the reaction is advantageously carried out at a temperature in the range of from about -20°C to about +180°C, preferably from about 0°C to about +80°C, in many instances in the range between room temperature and the reflux temperature of the reaction mixture.
- a compound II is reacted at -10°C to 40°C, preferably 0°C, with a chlorinating agent, preferably Javelle water.
- the reaction is preferably carried out at atmospheric pressure.
- reaction time is not critical; preference is given to a reaction time of 0.1 to 48 hours, in particular 0.5 to 24 hours.
- the product is isolated by customary methods, for example filtration, crystallization, distillation or chromatography or any suitable combination of these procedures.
- Suitable leaving groups Xi in the compounds IV are for example hydroxy, C 1 -C 8 alkoxy, halo- C 1 -C 8 alkoxy, C 1 -C 8 alkanoyloxy, mercapto, C 1 -C 8 alkylthio, halo-C 1 -C 8 alkylthio,
- Bases suitable for facilitating the reaction are for example alkali metal or alkaline earth metal hydroxides, hydrides, amides, alkanolates, acetates, carbonates, dialkylamides or alkylsilylamides, alkyiamines, alkylenediamines, free or N-alkylated, saturated or
- unsaturated cycloalkylamines, basic heterocycles, ammonium hydroxides and also carbocyclic amines examples are sodium hydroxide, sodium hydride, sodium amide, sodium methanolate, sodium acetate, sodium carbonate, potassium tert-butanolate, potassium hydroxide, potassium carbonate, potassium hydride, lithium diisopropylamide, potassium bis(trimethylsilyl)amide, calciumhydride, triethylamine, diisopropylethylamine, triethylenediamine, cyclohexylamine, N-cyclohexyl-N,N-dimethylamine, N,N-diethylaniline, pyridine, 4-(N,N-dimethylamino)pyridine, quinuclidine, N-methylmorpholine, benzyltrimethylammonium hydroxide and also 1 ,5-diazabicyclo[5.4.0]undec-5-ene (DBU).
- DBU 1 ,
- solvents or diluents are: water; aromatic, aliphatic and alicyclic hydrocarbons and halogenated hydrocarbons, such as benzene, toluene, xylene, mesitylene, tetraline, chlorobenzene, dichlorobenzene, bromobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, trichloromethane, carbon tetrachloride, dichloroethane, trichloroethene or tetrachloroethene; esters, such as ethyl acetate; ethers, such as diethyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol dimethyl ether, dimethoxydie
- the reaction can also be carried out in a heterogeneous two-phase mixture, for example a mixture of an organic solvent and an aqueous solution of a base, if necessary in the presence of a phase-transfer catalyst such as a crown ether or a tetraalkylammonium salt.
- a phase-transfer catalyst such as a crown ether or a tetraalkylammonium salt.
- the reaction is advantageously carried out at a temperature in the range of from about 0°C to about +180°C, preferably from about +10°C to about +80°C, in many instances in the range between room temperature and the reflux temperature of the reaction mixture.
- the reaction is preferably carried out at atmospheric pressure.
- reaction time is not critical; preference is given to a reaction time of 0.1 to 48 hours, in particular 0.5 to 24 hours.
- the product is isolated by customary methods, for example filtration, crystallization, distillation or chromatography or any suitable combination of these procedures.
- Suitable halogenating agents are for example of the kind stated under variant a).
- reaction partners can be reacted with each other as such, i.e. without the addition of a solvent or diluent, for example in the melt. In most instances, however, the addition of a solvent or diluent or a mixture thereof is advantageous. Suitable solvents or diluents are for example of the kind stated under variant a).
- the reaction is advantageously carried out at a temperature in the range of from about -20°C to about +180°C, preferably from about 0°C to about +80oC, in many instances between room temperature and the reflux temperature of the reaction mixture.
- a compound II is reacted with a chlorinating agent, preferably elemental chlorine or Javelle water, at -10°C to 40°C, preferably 0°C.
- a chlorinating agent preferably elemental chlorine or Javelle water
- the reaction is preferably carried out at atmospheric pressure.
- reaction time is not critical; preference is given to a reaction time of 0.1 to 48 hours, in particular 0.5 to 24 hours.
- the product is isolated by customary methods, for example filtration, crystallization, distillation or chromatography or any suitable combination of these procedures.
- Novel starting materials or intermediates in each case either in their free form or as salts, that are used according to the invention for preparing compounds of the formulae I, II, IV or VII or their salts, respectively, a process for their preparation and their use as starting materials or intermediates for preparing the compounds I, II, IV or VII also form part of the subject-matter of the invention.
- the compounds II can be prepared for example as described under variant b1).
- the compounds of the formula IV can - for instance - also be obtained by reacting a compound of the formula wherein R 6 has the meanings given for formula II, with a compound of the formula QX 1 , wherein Q is an acidic group, preferably an inorganic acidic group, such as SO 2 X 1 , and X 1 has the meanings given for formula II, in order to obtain a compound of the formula IV, wherein n 0 ist, and - if desired - further reacting the compound of the formula IV, wherein n is 0, with an oxidizing agent, such as hydrogenperoxid, in order to obtain a compound of the formula IV, wherein n is 1 or 2.
- an oxidizing agent such as hydrogenperoxid
- the compounds of the formula VII can for instance be obtained by reacting a compound of the formula VI with a compound of the formula R 6 X 2 , wherein R 6 has the meaning as given for formula II and X 2 is a leaving group, preferably in the presence of a base.
- the invention relates to all those embodiments of the process which are based on starting materials or intermediates obtainable from any stage of the process and in which all or some of the missing steps are carried out or in which a starting material is used or, in particular, formed under the reaction conditions in the form of a derivative or salt and/or its racemates or enantiom ⁇ rs.
- the invention relates in particular to the processes described in Examples H1 to H8.
- Example H2 3-(2-Benzylthiothiazol-5-ylmethyl)-5-methyl-4-nitroimino-perhvdro-1 ,3,5- oxadiazine (Compound No. 2.9 in Table 2)
- Example H4 3-(2-Chlorothiazol-5-ylmethvl)-5-methyl-4-nitroimino-perhydro-1 ,3,5-oxadiazine (Compound No. 11.1 in Table 11 )
- Example H5 3-(2-Chlorothiazol-5-ylmethyl)-5-methyl-4-nitroimino-perhydro-1 ,3,5-oxadiazine (Compound No. 11.1 in Table 11 )
- Example H6 3-(2-Chlorothiazol-5-vlmethvl)-5-methyl-4-nitroimino-perhvdro-1 ,3,5-oxadiazine (Compound No. 11.1 in Table 11 )
- Example H8 Analogously to the procedures described in Examples H1 to H7, also the other compounds listed in Tables 1 to 13 can be prepared.
- the temperatures stated in the column "Physical data" of these tables in each case denote the melting point of the respective compound; “decomp.” means decomposition.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9903701A HUP9903701A3 (en) | 1995-12-01 | 1996-12-02 | Process for the preparation of 2-chlorothiazole derivatives, intermediates and preparation thereof |
DE69635421T DE69635421T2 (de) | 1995-12-01 | 1996-12-02 | Verfahren zur herstellung von 2-chlorthiazolderivaten |
PL96326973A PL189519B1 (pl) | 1995-12-01 | 1996-12-02 | Sposób wytwarzania związków 2-chlorotiazolowych, sposób wytwarzania związków pośrednich oraz związki pośrednie |
CA002237348A CA2237348C (en) | 1995-12-01 | 1996-12-02 | Process for preparing 2-chlorothiazole compounds |
JP52111697A JP4142100B2 (ja) | 1995-12-01 | 1996-12-02 | 2―クロロチアゾール化合物の製法 |
KR10-2004-7015572A KR100519189B1 (ko) | 1995-12-01 | 1996-12-02 | 2-클로로티아졸 화합물 제조용 중간체 및 이의 제조방법 |
IL12431196A IL124311A0 (en) | 1995-12-01 | 1996-12-02 | Process for preparing 2-chlorothiazole compounds |
IL13917496A IL139174A (en) | 1995-12-01 | 1996-12-02 | Intermediate product in the preparation of compounds 2 - chlorothiazole |
IL13917596A IL139175A (en) | 1995-12-01 | 1996-12-02 | An intermediate compound in the process of making compounds of 2-chlorothiazole |
BR9611666A BR9611666A (pt) | 1995-12-01 | 1996-12-02 | Processo para preparar compostos de 2-clorotiazol |
AU76368/96A AU7636896A (en) | 1995-12-01 | 1996-12-02 | Process for preparing 2-chlorothiazole compounds |
AT96939236T ATE309230T1 (de) | 1995-12-01 | 1996-12-02 | Verfahren zur herstellung von 2- chlorthiazolderivaten |
EP96939236A EP0873326B1 (en) | 1995-12-01 | 1996-12-02 | Process for preparing 2-chlorothiazole compounds |
US09/077,569 US6211381B1 (en) | 1995-12-01 | 1996-12-02 | Thiazole compounds |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH3412/95 | 1995-12-01 | ||
CH341295 | 1995-12-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997020829A1 true WO1997020829A1 (en) | 1997-06-12 |
Family
ID=4255435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB1996/001329 WO1997020829A1 (en) | 1995-12-01 | 1996-12-02 | Process for preparing 2-chlorothiazole compounds |
Country Status (21)
Country | Link |
---|---|
US (1) | US6211381B1 (da) |
EP (1) | EP0873326B1 (da) |
JP (1) | JP4142100B2 (da) |
KR (2) | KR100519189B1 (da) |
CN (2) | CN1083446C (da) |
AR (1) | AR004984A1 (da) |
AT (1) | ATE309230T1 (da) |
AU (1) | AU7636896A (da) |
BR (1) | BR9611666A (da) |
CA (2) | CA2237348C (da) |
CZ (2) | CZ295996B6 (da) |
DE (1) | DE69635421T2 (da) |
DK (1) | DK0873326T3 (da) |
ES (1) | ES2252762T3 (da) |
HU (1) | HUP9903701A3 (da) |
IL (3) | IL139174A (da) |
MX (1) | MX9804301A (da) |
PL (1) | PL189519B1 (da) |
TW (1) | TW480255B (da) |
WO (1) | WO1997020829A1 (da) |
ZA (1) | ZA9610046B (da) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998027075A1 (en) * | 1996-12-19 | 1998-06-25 | Novartis Ag | Preparation of thiazoles |
WO1998027074A1 (en) * | 1996-12-19 | 1998-06-25 | Novartis Ag | Process for the preparation of thiazole derivatives |
WO2006049232A1 (ja) * | 2004-11-04 | 2006-05-11 | Mitsubishi Pharma Corporation | チアゾール環を含むカルボン酸誘導体およびその医薬用途 |
EP2065374A1 (de) * | 2007-11-30 | 2009-06-03 | Bayer CropScience AG | 2-(Benzyl- und 1H-pyrazol-4-ylmethyl)sulfinyl-Thiazol-Derivate als Herbizide und Pflanzenwachstumsregulatoren |
JPWO2007126043A1 (ja) * | 2006-04-27 | 2009-09-10 | 田辺三菱製薬株式会社 | チアゾール環を含むカルボン酸誘導体の医薬用途 |
AU2015203829B2 (en) * | 2007-11-30 | 2017-02-23 | Bayer Intellectual Property Gmbh | 2-(benzyl- and 1H-pyrazol-4-ylmethyl)sulfinyl thiazole derivatives as herbicides and plant growth regulators |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW240163B (en) * | 1992-07-22 | 1995-02-11 | Syngenta Participations Ag | Oxadiazine derivatives |
DE4425145A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Verwendung von Thiazol- und Thiadiazolverbindungen |
CN1196689C (zh) * | 2000-08-23 | 2005-04-13 | 辛根塔参与股份公司 | 制备杀虫氯噻唑的连续方法 |
JP2011193857A (ja) * | 2010-03-24 | 2011-10-06 | Sumitomo Chemical Co Ltd | N−カルバモイルアミノ化合物の製造方法 |
GB2514927B (en) * | 2014-05-28 | 2019-04-17 | Rotam Agrochem Int Co Ltd | Thiamethoxam and uses thereof |
WO2016057931A1 (en) | 2014-10-10 | 2016-04-14 | The Research Foundation For The State University Of New York | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration |
KR20190123293A (ko) * | 2017-02-26 | 2019-10-31 | 오에이티 아그리오 가부시키가이샤 | 티아졸 화합물 및 제초제 |
CN107474022B (zh) * | 2017-09-07 | 2020-06-26 | 连云港立本作物科技有限公司 | 噻唑基新烟碱化合物及其制备方法和应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0192060A1 (de) * | 1985-02-04 | 1986-08-27 | Nihon Bayer Agrochem K.K. | Heterocyclische Verbindungen |
EP0285985A1 (de) * | 1987-04-10 | 1988-10-12 | Bayer Ag | 3-Substituierte 1-(2-Chlorthiazol-5-yl-methyl)-2-nitroimino-1,3-diazacycloalkane |
EP0376279A2 (en) * | 1988-12-27 | 1990-07-04 | Takeda Chemical Industries, Ltd. | Guanidine derivatives, their production and insecticides |
EP0471372A1 (en) * | 1990-08-17 | 1992-02-19 | Takeda Chemical Industries, Ltd. | Novel substituted guanidine derivatives, their preparation and use |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR920000756A (ko) * | 1990-06-18 | 1992-01-29 | 마사히꼬 후루까와 | 피라졸카르복시아미드, 살충 및 살비 조성물, 및 농업 및 원예업에 유용한 살진균 조성물 |
-
1996
- 1996-11-29 ZA ZA9610046A patent/ZA9610046B/xx unknown
- 1996-12-01 TW TW085114834A patent/TW480255B/zh not_active IP Right Cessation
- 1996-12-02 CN CN96198745A patent/CN1083446C/zh not_active Expired - Fee Related
- 1996-12-02 CA CA002237348A patent/CA2237348C/en not_active Expired - Fee Related
- 1996-12-02 JP JP52111697A patent/JP4142100B2/ja not_active Expired - Fee Related
- 1996-12-02 DE DE69635421T patent/DE69635421T2/de not_active Expired - Lifetime
- 1996-12-02 BR BR9611666A patent/BR9611666A/pt not_active IP Right Cessation
- 1996-12-02 AR ARP960105458A patent/AR004984A1/es active IP Right Grant
- 1996-12-02 AT AT96939236T patent/ATE309230T1/de active
- 1996-12-02 IL IL13917496A patent/IL139174A/en not_active IP Right Cessation
- 1996-12-02 CZ CZ19981664A patent/CZ295996B6/cs not_active IP Right Cessation
- 1996-12-02 IL IL13917596A patent/IL139175A/en not_active IP Right Cessation
- 1996-12-02 IL IL12431196A patent/IL124311A0/xx not_active IP Right Cessation
- 1996-12-02 AU AU76368/96A patent/AU7636896A/en not_active Abandoned
- 1996-12-02 WO PCT/IB1996/001329 patent/WO1997020829A1/en active IP Right Grant
- 1996-12-02 US US09/077,569 patent/US6211381B1/en not_active Expired - Lifetime
- 1996-12-02 CA CA002591794A patent/CA2591794A1/en not_active Abandoned
- 1996-12-02 DK DK96939236T patent/DK0873326T3/da active
- 1996-12-02 PL PL96326973A patent/PL189519B1/pl not_active IP Right Cessation
- 1996-12-02 HU HU9903701A patent/HUP9903701A3/hu unknown
- 1996-12-02 EP EP96939236A patent/EP0873326B1/en not_active Expired - Lifetime
- 1996-12-02 ES ES96939236T patent/ES2252762T3/es not_active Expired - Lifetime
- 1996-12-02 CZ CZ20033398A patent/CZ301539B6/cs not_active IP Right Cessation
- 1996-12-02 KR KR10-2004-7015572A patent/KR100519189B1/ko not_active IP Right Cessation
- 1996-12-02 KR KR10-1998-0704017A patent/KR100489160B1/ko not_active IP Right Cessation
-
1998
- 1998-05-29 MX MX9804301A patent/MX9804301A/es unknown
-
2001
- 2001-05-18 CN CNB011195185A patent/CN1219773C/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0192060A1 (de) * | 1985-02-04 | 1986-08-27 | Nihon Bayer Agrochem K.K. | Heterocyclische Verbindungen |
EP0285985A1 (de) * | 1987-04-10 | 1988-10-12 | Bayer Ag | 3-Substituierte 1-(2-Chlorthiazol-5-yl-methyl)-2-nitroimino-1,3-diazacycloalkane |
EP0376279A2 (en) * | 1988-12-27 | 1990-07-04 | Takeda Chemical Industries, Ltd. | Guanidine derivatives, their production and insecticides |
EP0471372A1 (en) * | 1990-08-17 | 1992-02-19 | Takeda Chemical Industries, Ltd. | Novel substituted guanidine derivatives, their preparation and use |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7538229B2 (en) | 1996-12-19 | 2009-05-26 | Syngenta Crop Protection, Inc. | Preparation of thiazoles |
US7323564B2 (en) | 1996-12-19 | 2008-01-29 | Syngenta Crop Protection, Inc. | Preparation of thiazoles |
US6121455A (en) * | 1996-12-19 | 2000-09-19 | Novartis Crop Protection, Inc. | Process for the preparation of thiazole derivatives |
US6369233B1 (en) | 1996-12-19 | 2002-04-09 | Syngenta Crop Protection, Inc. | Process for the preparation of thiazole derivatives |
EP1201662A1 (en) * | 1996-12-19 | 2002-05-02 | Syngenta Participations AG | Preparation of thiazoles |
US6548676B1 (en) | 1996-12-19 | 2003-04-15 | Syngenta Crop Protection, Inc. | Preparation of thiazoles |
EP1577307A2 (en) * | 1996-12-19 | 2005-09-21 | Syngenta Participations AG | Preparation of thiazoles |
US7795442B2 (en) | 1996-12-19 | 2010-09-14 | Syngenta Crop Protection, Inc. | Preparation of thiazoles |
US7161011B2 (en) | 1996-12-19 | 2007-01-09 | Syngenta Crop Protection, Inc. | Preparation of thiazoles |
WO1998027075A1 (en) * | 1996-12-19 | 1998-06-25 | Novartis Ag | Preparation of thiazoles |
EP1577307A3 (en) * | 1996-12-19 | 2009-04-29 | Syngenta Participations AG | Preparation of thiazoles |
WO1998027074A1 (en) * | 1996-12-19 | 1998-06-25 | Novartis Ag | Process for the preparation of thiazole derivatives |
JPWO2006049232A1 (ja) * | 2004-11-04 | 2008-05-29 | 田辺三菱製薬株式会社 | チアゾール環を含むカルボン酸誘導体およびその医薬用途 |
JP4939226B2 (ja) * | 2004-11-04 | 2012-05-23 | 田辺三菱製薬株式会社 | チアゾール環を含むカルボン酸誘導体およびその医薬用途 |
KR100918523B1 (ko) * | 2004-11-04 | 2009-09-21 | 미쓰비시 타나베 파마 코퍼레이션 | 티아졸환을 포함하는 카르복실산 유도체 및 그의 의약 용도 |
US8026370B2 (en) | 2004-11-04 | 2011-09-27 | Mitsubishi Tanabe Pharma Corporation | Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof |
WO2006049232A1 (ja) * | 2004-11-04 | 2006-05-11 | Mitsubishi Pharma Corporation | チアゾール環を含むカルボン酸誘導体およびその医薬用途 |
JP5225076B2 (ja) * | 2006-04-27 | 2013-07-03 | 田辺三菱製薬株式会社 | チアゾール環を含むカルボン酸誘導体の医薬用途 |
JPWO2007126043A1 (ja) * | 2006-04-27 | 2009-09-10 | 田辺三菱製薬株式会社 | チアゾール環を含むカルボン酸誘導体の医薬用途 |
WO2009068170A3 (de) * | 2007-11-30 | 2009-09-03 | Bayer Cropscience Ag | 2- (benzyl- und 1h- pyrazol-4 -ylmethyl) sulfinyl-thiazol-derivate als herbizide und pflanzenwachstumsregulatoren |
EP2065374A1 (de) * | 2007-11-30 | 2009-06-03 | Bayer CropScience AG | 2-(Benzyl- und 1H-pyrazol-4-ylmethyl)sulfinyl-Thiazol-Derivate als Herbizide und Pflanzenwachstumsregulatoren |
WO2009068170A2 (de) * | 2007-11-30 | 2009-06-04 | Bayer Cropscience Ag | 2- (benzyl- und 1h- pyrazol-4 -ylmethyl) sulfinyl-thiazol-derivate als herbizide und pflanzenwachstumsregulatoren |
US8754234B2 (en) | 2007-11-30 | 2014-06-17 | Bayer Cropscience Ag | Chiral 2-(benzylsulfinyl)thiazole derivatives and 2-[(1H-pyrazol-4-ylmethyl)sulfinyl]thiazole derivatives, processes for their preparation and their use as herbicides and plant growth regulators |
AU2015203829B2 (en) * | 2007-11-30 | 2017-02-23 | Bayer Intellectual Property Gmbh | 2-(benzyl- and 1H-pyrazol-4-ylmethyl)sulfinyl thiazole derivatives as herbicides and plant growth regulators |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0873326B1 (en) | Process for preparing 2-chlorothiazole compounds | |
US20110306772A1 (en) | Process for the preparation of 2-chloro-5-chloromethyl-thiazole | |
US6187927B1 (en) | Process for preparing a 2-chloro-5-chloromethyl-thiazole compound | |
EP0946531B1 (en) | Process for the preparation of thiazole derivatives | |
WO1997023469A9 (en) | Process for the preparation of 2-chloro-5-chloromethyl-thiazole | |
KR100520249B1 (ko) | 티아졸 유도체의 제조 방법 | |
CA1321594C (en) | Process for the preparation of nitroethene derivatives | |
AU2002300672B2 (en) | Process for preparing 2-chlorothiazole compounds | |
AU2006200339B2 (en) | Process for preparing 2-chlorothiazole compounds | |
US6121476A (en) | Process for preparing dithiocarbonimide derivatives | |
US20240101547A1 (en) | Method for preparing 2-[2-(2-chlorothiazol-5-yl)-2-oxo-ethyl]sulfanyl-6-hydroxy-3-methyl-5-phenyl-pyrimidin-4-one | |
PL195975B1 (pl) | Sposób wytwarzania pochodnej 2-aminotiazolokarboksyamidu i związki pośrednie | |
WO1997014688A1 (en) | A PROCESS FOR THE PREPARATION OF α-CHLOROMETHYLPHENYLACETIC ACID DERIVATIVES | |
HU196957B (en) | Process for producing o-carbamoyl-methyl-esters of n'-/acyl-hydrazine/-n-thiocarboxylic acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 96198745.6 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AU BA BB BG BR CA CN CU CZ EE GE HU IL IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK TR TT UA US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1996939236 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2237348 Country of ref document: CA Ref document number: 2237348 Country of ref document: CA Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 1997 521116 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV1998-1664 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019980704017 Country of ref document: KR Ref document number: PA/a/1998/004301 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09077569 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: PV1998-1664 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1996939236 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019980704017 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 139175 Country of ref document: IL Ref document number: 139174 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2003-3398 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 1019980704017 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1996939236 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: PV1998-1664 Country of ref document: CZ |